182 related articles for article (PubMed ID: 18251667)
1. Prevention and treatment of enterohemorrhagic Escherichia coli infections in humans.
Orth D; Grif K; Zimmerhackl LB; Würzner R
Expert Rev Anti Infect Ther; 2008 Feb; 6(1):101-8. PubMed ID: 18251667
[TBL] [Abstract][Full Text] [Related]
2. The role of virulence factors in enterohemorrhagic Escherichia coli (EHEC)--associated hemolytic-uremic syndrome.
Karch H
Semin Thromb Hemost; 2001 Jun; 27(3):207-13. PubMed ID: 11446654
[TBL] [Abstract][Full Text] [Related]
3. Shiga toxin-negative attaching and effacing Escherichia coli: distinct clinical associations with bacterial phylogeny and virulence traits and inferred in-host pathogen evolution.
Bielaszewska M; Middendorf B; Köck R; Friedrich AW; Fruth A; Karch H; Schmidt MA; Mellmann A
Clin Infect Dis; 2008 Jul; 47(2):208-17. PubMed ID: 18564929
[TBL] [Abstract][Full Text] [Related]
4. Shiga toxin activates complement and binds factor H: evidence for an active role of complement in hemolytic uremic syndrome.
Orth D; Khan AB; Naim A; Grif K; Brockmeyer J; Karch H; Joannidis M; Clark SJ; Day AJ; Fidanzi S; Stoiber H; Dierich MP; Zimmerhackl LB; Würzner R
J Immunol; 2009 May; 182(10):6394-400. PubMed ID: 19414792
[TBL] [Abstract][Full Text] [Related]
5. [Enterohemorrhagic Escherichia coli (EHEC) infection in infants and children].
Jimbo K; Shimizu T
Nihon Rinsho; 2012 Aug; 70(8):1338-42. PubMed ID: 22894068
[TBL] [Abstract][Full Text] [Related]
6. Oral therapeutic agents with highly clustered globotriose for treatment of Shiga toxigenic Escherichia coli infections.
Watanabe M; Matsuoka K; Kita E; Igai K; Higashi N; Miyagawa A; Watanabe T; Yanoshita R; Samejima Y; Terunuma D; Natori Y; Nishikawa K
J Infect Dis; 2004 Feb; 189(3):360-8. PubMed ID: 14745692
[TBL] [Abstract][Full Text] [Related]
7. Enterohemorrhagic Escherichia coli Infections and the Hemolytic-Uremic Syndrome.
Page AV; Liles WC
Med Clin North Am; 2013 Jul; 97(4):681-95, xi. PubMed ID: 23809720
[TBL] [Abstract][Full Text] [Related]
8. Enterohaemorrhagic Escherichia coli O26:H11/H-: a human pathogen in emergence.
Bielaszewska M; Zhang W; Mellmann A; Karch H
Berl Munch Tierarztl Wochenschr; 2007; 120(7-8):279-87. PubMed ID: 17715820
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology and pathogenesis of enterohaemorrhagic Escherichia coil.
Karch H; Mellmann A; Bielaszewska M
Berl Munch Tierarztl Wochenschr; 2009; 122(11-12):417-24. PubMed ID: 19999376
[TBL] [Abstract][Full Text] [Related]
10. Treatment and prevention of enterohemorrhagic Escherichia coli infection and hemolytic uremic syndrome.
Goldwater PN
Expert Rev Anti Infect Ther; 2007 Aug; 5(4):653-63. PubMed ID: 17678428
[TBL] [Abstract][Full Text] [Related]
11. Occurrence and characteristics of enterohemorrhagic Escherichia coli O26 and O111 in calves associated with diarrhea.
Lee JH; Hur J; Stein BD
Vet J; 2008 May; 176(2):205-9. PubMed ID: 17400008
[TBL] [Abstract][Full Text] [Related]
12. Preservation of protective capacity of hyperimmune anti-Stx2 bovine colostrum against enterohemorrhagic Escherichia coli O157:H7 pathogenicity after pasteurization and spray-drying processes.
Garimano N; Diaz Vergara LI; Kim AD; Badin EE; Sodero S; Bernal AM; Gonzalez DD; Amaral MM; Lespinard AR; Porporatto C; Montenegro MA; Palermo MS; Larzabal M; Cataldi AA; Ibarra C; Sacerdoti F
J Dairy Sci; 2021 May; 104(5):5229-5238. PubMed ID: 33685676
[TBL] [Abstract][Full Text] [Related]
13. Treatment of typical (enteropathic) hemolytic uremic syndrome.
Bitzan M; Schaefer F; Reymond D
Semin Thromb Hemost; 2010 Sep; 36(6):594-610. PubMed ID: 20865636
[TBL] [Abstract][Full Text] [Related]
14. Shiga toxin-producing Escherichia coli and their bacteriophages as a model for the analysis of virulence and stress response of a food-borne pathogen.
Creuzburg K; Schmidt H
Berl Munch Tierarztl Wochenschr; 2007; 120(7-8):288-95. PubMed ID: 17715821
[TBL] [Abstract][Full Text] [Related]
15. [Enterohemorrhagic E. coli (EHEC)].
Goto T; Shirano M
Nihon Rinsho; 2012 Aug; 70(8):1343-7. PubMed ID: 22894069
[TBL] [Abstract][Full Text] [Related]
16. The Fatal Role of Enterohaemorrhagic Escherichia coli Shiga Toxin-associated Extracellular Vesicles in Host Cells.
Lee KS; Park JY; Jeong YJ; Lee MS
J Microbiol; 2023 Aug; 61(8):715-727. PubMed ID: 37665555
[TBL] [Abstract][Full Text] [Related]
17. Enterohemorrhagic Escherichia coli infection has donor-dependent effect on human gut microbiota and may be antagonized by probiotic yeast during interaction with Peyer's patches.
Thévenot J; Cordonnier C; Rougeron A; Le Goff O; Nguyen HT; Denis S; Alric M; Livrelli V; Blanquet-Diot S
Appl Microbiol Biotechnol; 2015 Nov; 99(21):9097-110. PubMed ID: 26084888
[TBL] [Abstract][Full Text] [Related]
18. The serine 31 residue of the B subunit of Shiga toxin 2 is essential for secretion in enterohemorrhagic Escherichia coli.
Shimizu T; Kawakami S; Sato T; Sasaki T; Higashide M; Hamabata T; Ohta T; Noda M
Infect Immun; 2007 May; 75(5):2189-200. PubMed ID: 17325057
[TBL] [Abstract][Full Text] [Related]
19. Enterohemorrhagic Escherichia coli (EHEC).
Welinder-Olsson C; Kaijser B
Scand J Infect Dis; 2005; 37(6-7):405-16. PubMed ID: 16011999
[TBL] [Abstract][Full Text] [Related]
20. [Clinical symptoms, treatment and outcome of EHEC and EHEC-HUS patients treated as in-patients].
Dücker C; Dautel P; Wagner K; Przewozna J; Oehlerking S; Repenthin J; Brüning R; Meyer TN; Faiss S
Dtsch Med Wochenschr; 2011 Sep; 136(36):1770-6. PubMed ID: 21882131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
